Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Navitian Post-Market Clinical Follow-up Study

NCT05292118 is registered in ClinicalTrials.gov with Fundación EPIC as lead sponsor.

NCT NCT05292118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05292118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Navitian Post-Market Clinical Follow-up Study
Lead sponsor
Fundación EPIC
Phase
Observational
Overall status
Completed
Start date
September 26, 2022
Completion date
July 11, 2024
Enrollment
102 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad), ischemic heart disease